The University of Tennessee Graduate School of Medicine Department of Anesthesiology presents the Annual Targeted Pain Treatment® Conference: STOP the Stigma on March 28, 2025 at the Hilton Knoxville Airport.
This conference will address the opioid crisis in East Tennessee by providing healthcare providers with up-to-date, evidence-based information on alternative pain management options. The course will focus on dispelling the stigma surrounding both opioid and non-opioid treatments, increasing awareness and application of state and national guidelines, and enhancing education on the multimodal approaches to pain care. By identifying and overcoming barriers to access, the conference aims to improve patient outcomes, function, and quality of life for those suffering from acute and chronic pain.
At the conclusion of this program, the participants should be able to:
Targeted Pain Treatment® the process of accurately diagnosing the cause of pain, and then targeting the treatment to the cause, is an alternate, effective, and comprehensive approach to addressing the cause of pain and improving function and quality of life for patients.
This conference is officially endorsed by the Tennessee Pain Society.
Requirements for continuing medical education credit regarding controlled substance prescribing
Targeted Pain Treatment® is a federally registered trademark owned by Dr. Stephanie Vanterpool. Dr. Vanterpool developed and is responsible for the content contained in the TPT Toolkit.
Course DirectorsStephanie G. Vanterpool MD, MBA, FASA Hannah Denham, PharmD, BCPS |
Registration FeesFees include access to online program materials, continuing education credit hours, breakfast, lunch, and breaks, and parking at the Hilton Knoxville Airport. | |||
Earlybird | February 19, 2025 | ||
Physician or PharmD | $200 | $250 | |
Non-Physician | $150 | $200 | |
Resident and Students (no CME credit) | $25 | $50 |
The University of Tennessee College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Tennessee College of Medicine designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants, Nurse Practitioners and Nurses may use these credit hours toward certification renewal. This credit is acceptable by the American Academy of Physician Assistants (AAPA), American Nurses Credentialing Association (ANCC) and the American Academy of Nurse Practitioners (AANP).
The Credit request is pending.
There is no minimum threshold for financial disclosures; individuals must disclose all financial relationships, regardless of the amount, with ineligible companies within the past 24 months. Individuals must disclose regardless of their view of the relevance of the relationship to the education. Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.
The UT Graduate School of Medicine Office of Continuing Education and Professional Development along with the Co-Course Directors have taken appropriate steps to mitigate relationships prior to the individuals assuming their roles. CME Planning Staff have no actual or potential conflicts of interest in relation to the presentations.
The University of Tennessee Graduate School of Medicine
1924 Alcoa Highway
Knoxville, Tennessee 37920 | 865-305-9290
Copyright © 2024